Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Regado misses IPO fiesta, limps into public spotlight with $43M raise
Fierce Biotech
Thursday, August 22, 2013 - 10:08am
tags:
IPOs, Regado Biosciences
Four Promising Biotech Stocks With Upcoming Catalysts
Minyanville
Thursday, August 22, 2013 - 10:05am
tags:
GSK, Sarepta, Gilead, sofosbuvir, SGX203, SGX942, Soligenix, drisapersen
Alexza Expects 2nd Half Of 2013 And 2014 To Be Eventful
Seeking Alpha
Thursday, August 22, 2013 - 9:18am
tags:
Alexza, Teva, Adasuve
Cytokinetics publishes results from tirasemtiv Phase II trials in ALS patients
Yahoo/Fly on the Wall
Thursday, August 22, 2013 - 9:16am
tags:
Cytokinetics, ALS, Tirasemtiv
Does Incyte Deserve Its New Valuation?
Motley Fool
Thursday, August 22, 2013 - 9:14am
tags:
Incyte, JAK inhibitors, Jakafi, pancreatic cancer
Analysts: Device companies already absorbed excise tax
Mass Device
Thursday, August 22, 2013 - 9:12am
tags:
devices, excise tax, device tax
FDA clears Novo Nordisk insulin pen for children
Drugstore News
Thursday, August 22, 2013 - 9:11am
tags:
insulin pen, FDA, Novo Nordisk, NovoPen Echo, type 1 diabetes
Teva Chairman Frost Backs Management Amid Criticism From Goldman
Bloomberg
Thursday, August 22, 2013 - 9:09am
tags:
Teva, Phillip Frost
Challenges In Commercializing Inhaled Insulin
Forbes
Thursday, August 22, 2013 - 9:08am
tags:
inhaled insulin, Afrezza, MannKind
Eli Lilly says 'deeply concerned' by bribery allegations in China
Yahoo/Reuters
Thursday, August 22, 2013 - 9:07am
tags:
Eli Lilly, China
This Small Company Is Winning the War Against Blood Cancer
Motley Fool
Wednesday, August 21, 2013 - 6:59pm
tags:
Pharmacyclics, mantle cell lymphoma, small lymphocytic lymphoma, chronic lymphocytic leukemia, ibrutinib
Exclusive: Onyx provides drug trial data to potential bidders - sources
Yahoo/Reuters
Wednesday, August 21, 2013 - 6:58pm
tags:
ONYX Pharmaceuticals, M&A, Amgen, clinical trials, Kyprolis
Is Eli Lilly Destined for Greatness?
Motley Fool
Wednesday, August 21, 2013 - 6:53pm
tags:
Eli Lilly
1 in 5 Health Systems to Become Payers by 2018
Healthleaders Media
Wednesday, August 21, 2013 - 11:29am
tags:
health insurance, healthcare reform
NeoStem: A Three-Pronged Catalyst Story
Seeking Alpha
Wednesday, August 21, 2013 - 11:24am
tags:
NeoStem, AMR-101, Progenitor Cell Therapy, Baxter
Trial co-op persuades pharmas to stop sabotaging head-to-head drug studies
Fierce Biotech
Wednesday, August 21, 2013 - 11:22am
tags:
clinical trials
Basilea shares dented after FDA digs in on antibiotic PhIII rule
Fierce Biotech
Wednesday, August 21, 2013 - 11:16am
tags:
Basilea, ceftobiprole, FDA, antibiotics
Medtronic Plans Expansion to Health Services, CEO Says
Bloomberg
Wednesday, August 21, 2013 - 10:31am
tags:
devices, Medtronic
Allergan pushes FDA to defend Restasis from early generics
Fierce Pharma
Wednesday, August 21, 2013 - 10:20am
tags:
Allergan, Restasis, dry eye disease, FDA, generics
Soligenix: Poised To Take Off In 2014
Seeking Alpha
Wednesday, August 21, 2013 - 10:19am
tags:
Soligenix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.